Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia
Background. Serum hemeoxygenase-1 (HO-1) has been proposed to be a biomarker of lung disease activity and prognosis. The present study aimed at evaluating whether HO-1 could be a useful marker for evaluating disease activity and predicting prognosis in patients with interstitial pneumonia (IP). Mate...
Saved in:
| Main Authors: | Kota Murohashi, Yu Hara, Kanako Shinada, Kenjiro Nagai, Masaharu Shinkai, Akihiko Kawana, Takeshi Kaneko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/7260178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ELISA Development for Serum Hemeoxygenase-1 and Its Application to Patients with Acute Respiratory Distress Syndrome
by: Yu Hara, et al.
Published: (2018-01-01) -
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases
by: Yoichi Tagami, et al.
Published: (2021-01-01) -
The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease
by: Yurika Nishikawa, et al.
Published: (2021-01-01) -
Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease
by: Yun Zhang, et al.
Published: (2025-07-01) -
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
by: Hiroaki Fujii, et al.
Published: (2023-01-01)